Showing results (191-200 of 366) with videos related to
Sort By:
Pageof 37
Breast Cancer Research and Treatment|April 4, 2014
Long-term risk of medical conditions associated with breast cancer treatmentDeirdre A Hill, Nora K Horick, Claudine Isaacs, et al.JCO Precision Oncology|May 26, 2021
Integrating Clinical and Polygenic Factors to Predict Breast Cancer Risk in Women Undergoing Genetic TestingElisha Hughes, Placede Tshiaba, Susanne Wagner, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 25, 2023
Combination ATR (ceralasertib) and PARP (olaparib) Inhibitor (CAPRI) Trial in Acquired PARP Inhibitor-Resistant Homologous Recombination-Deficient Ovarian CancerStephanie L Wethington, Payal D Shah, Lainie Martin, et al.JAMA|July 14, 2011
Clinically relevant changes in family history of cancer over timeArgyrios Ziogas, Nora K Horick, Anita Y Kinney, et al.The Journal of Urology|March 28, 2023
Clinical Impact of a Rapid Genetic Testing Model for Advanced Prostate Cancer PatientsKelsey E Breen, Heather Symecko, Kelsey Spielman, et al.Nature Communications|November 7, 2022
Analysis of matched primary and recurrent BRCA1/2 mutation-associated tumors identifies recurrence-specific driversJennifer B Shah, Dana Pueschl, Bradley Wubbenhorst, et al.Nature Communications|April 9, 2026
Combining multiplexed assays of variant effect for enhanced BRCA2 variant classificationChunling Hu, Sounak Sahu, Wenan Chen, et al.Clinical Breast Cancer|February 14, 2008
Bilateral prophylactic oophorectomy and bilateral prophylactic mastectomy in a prospective cohort of unaffected BRCA1 and BRCA2 mutation carriersTara M Friebel, Susan M Domchek, Susan L Neuhausen, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 23, 2022
Classification of BRCA2 Variants of Uncertain Significance (VUS) Using an ACMG/AMP Model Incorporating a Homology-Directed Repair (HDR) Functional AssayChunling Hu, Lisa R Susswein, Maegan E Roberts, et al.Cell Reports|January 22, 2026
Immune gene diversity and STING1 variants in shaping cancer immunity across different genetic ancestry populationsXiaowen Hu, Jie Huang, Jiao Yuan, et al.Pageof 37